These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8762965)
21. Thrombocytopenic purpura: adverse reaction to a combined immunisation (recombinant hepatitis B and measles-mumps-rubella-vaccine) and after therapy with Co-trimoxazole. Müller A; Kertzscher F; Kiefel V; Lenk H Eur J Pediatr; 1999 Dec; 158 Suppl 3():S209-10. PubMed ID: 10650872 [No Abstract] [Full Text] [Related]
22. Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Nieminen U; Peltola H; Syrjälä MT; Mäkipernaa A; Kekomäki R Acta Paediatr; 1993 Mar; 82(3):267-70. PubMed ID: 8495082 [TBL] [Abstract][Full Text] [Related]
23. Indications for measles-mumps-rubella vaccination in a child with prior thrombocytopenia purpura. Pool V; Chen R; Rhodes P Pediatr Infect Dis J; 1997 Apr; 16(4):423-4. PubMed ID: 9109153 [No Abstract] [Full Text] [Related]
24. Evidence to support current policy on MMR vaccination sent to doctors in the United Kingdom. Commun Dis Rep CDR Wkly; 1998 Apr; 8(14):123, 126. PubMed ID: 9592964 [No Abstract] [Full Text] [Related]
25. MMR vaccine is not linked to Crohn's disease or autism. Commun Dis Rep CDR Wkly; 1998 Mar; 8(13):113. PubMed ID: 9592960 [No Abstract] [Full Text] [Related]
26. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of a trivalent measles, mumps, rubella vaccine in children. Bloom JL; Schiff GM; Graubarth H; Lipp RW; Jackson JE; Osborn RL; Kenny MT J Pediatr; 1975 Jul; 87(1):85-7. PubMed ID: 1151553 [No Abstract] [Full Text] [Related]
28. Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial. Swartz TA; Klingberg W; Klingberg MA Infection; 1974; 2(3):115-7. PubMed ID: 4606362 [No Abstract] [Full Text] [Related]
29. Measles, mumps, rubella vaccine: through a glass, darkly. Wakefield AJ; Montgomery SM Adverse Drug React Toxicol Rev; 2000 Dec; 19(4):265-83; discussion 284-92. PubMed ID: 11212459 [No Abstract] [Full Text] [Related]
30. Transverse myelitis after measles, mumps, and rubella vaccine. Joyce KA; Rees JE BMJ; 1995 Aug; 311(7002):422. PubMed ID: 7640590 [No Abstract] [Full Text] [Related]
31. Transverse myelitis unlikely to be due to measles, mumps, and rubella vaccine. Fescharek R; Dass H BMJ; 1995 Dec; 311(7020):1642. PubMed ID: 8555831 [No Abstract] [Full Text] [Related]
32. Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children. Watson BM; Laufer DS; Kuter BJ; Staehle B; White CJ; Starr SE J Infect Dis; 1996 Mar; 173(3):731-4. PubMed ID: 8627041 [TBL] [Abstract][Full Text] [Related]
33. Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious. King GE; Hadler SC Pediatr Infect Dis J; 1994 May; 13(5):394-407. PubMed ID: 8072822 [No Abstract] [Full Text] [Related]
34. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387 [TBL] [Abstract][Full Text] [Related]
35. Autism and measles, mumps, and rubella vaccine. Altmann D Lancet; 2000 Jan; 355(9201):409-10. PubMed ID: 10665582 [No Abstract] [Full Text] [Related]
36. [Incubation vaccination ("post-exposure vaccination") with MMR vaccine during a mumps epidemic? The Pediatric Vaccine Counseling Unit]. Wiersbitzky S; Bruns R; Beyer B Kinderarztl Prax; 1992 Oct; 60(7):207-8. PubMed ID: 1359187 [No Abstract] [Full Text] [Related]